Albemarle Corporation Logo

Albemarle Corporation

0HC7.L

(0.0)
Stock Price

87,75 USD

19.53% ROA

16.42% ROE

4.59x PER

Market Cap.

15.192.519.380,00 USD

34.16% DER

1.24% Yield

16.36% NPM

Albemarle Corporation Stock Analysis

Albemarle Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Albemarle Corporation Fundamental Stock Analysis
# Analysis Rating
1 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

2 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

3 ROE

Unidentified ROE

4 ROA

Unidentified ROA

5 PBV

Unidentified ROA

6 DER

Unidentified DER

7 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

9 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

10 Graham Number

Unidentified Graham Number

11 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

Albemarle Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Albemarle Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

Albemarle Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Albemarle Corporation Revenue
Year Revenue Growth
2012 2.519.154.000
2013 2.394.270.000 -5.22%
2014 2.445.548.000 2.1%
2015 2.826.429.000 13.48%
2016 2.677.203.000 -5.57%
2017 3.071.976.000 12.85%
2018 3.374.950.000 8.98%
2019 3.589.427.000 5.98%
2020 3.128.909.000 -14.72%
2021 3.327.957.000 5.98%
2022 7.320.104.000 54.54%
2023 9.242.384.000 20.8%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Albemarle Corporation Research and Development Expenses
Year Research and Development Expenses Growth
2012 78.919.000
2013 82.246.000 4.05%
2014 88.310.000 6.87%
2015 89.187.000 0.98%
2016 80.475.000 -10.83%
2017 84.330.000 4.57%
2018 70.054.000 -20.38%
2019 58.287.000 -20.19%
2020 59.214.000 1.57%
2021 54.026.000 -9.6%
2022 71.981.000 24.94%
2023 84.328.000 14.64%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Albemarle Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Albemarle Corporation EBITDA
Year EBITDA Growth
2012 590.268.000
2013 705.352.000 16.32%
2014 427.810.000 -64.88%
2015 707.679.000 39.55%
2016 727.602.000 2.74%
2017 843.547.000 13.74%
2018 950.379.000 11.24%
2019 943.250.000 -0.76%
2020 742.455.000 -27.04%
2021 865.159.000 14.18%
2022 2.867.504.000 69.83%
2023 -90.664.000 3262.78%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Albemarle Corporation Gross Profit
Year Gross Profit Growth
2012 898.843.000
2013 850.471.000 -5.69%
2014 770.848.000 -10.33%
2015 916.133.000 15.86%
2016 970.306.000 5.58%
2017 1.145.271.000 15.28%
2018 1.234.756.000 7.25%
2019 1.258.478.000 1.88%
2020 996.853.000 -26.25%
2021 1.008.471.000 1.15%
2022 3.077.787.000 67.23%
2023 219.736.000 -1300.67%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Albemarle Corporation Net Profit
Year Net Profit Growth
2012 307.255.000
2013 409.063.000 24.89%
2014 202.847.000 -101.66%
2015 302.430.000 32.93%
2016 441.544.000 31.51%
2017 54.850.000 -705%
2018 693.562.000 92.09%
2019 533.227.999 -30.07%
2020 375.764.000 -41.91%
2021 123.672.000 -203.84%
2022 2.689.816.000 95.4%
2023 1.210.132.000 -122.27%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Albemarle Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 3
2013 5 25%
2014 3 -100%
2015 3 0%
2016 4 33.33%
2017 0 0%
2018 6 100%
2019 5 -20%
2020 4 -66.67%
2021 1 -200%
2022 23 95.45%
2023 10 -120%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Albemarle Corporation Free Cashflow
Year Free Cashflow Growth
2012 207.893.000
2013 277.513.000 25.09%
2014 382.033.000 27.36%
2015 133.161.000 -186.9%
2016 538.870.000 75.29%
2017 -13.724.000 4026.48%
2018 -153.826.000 91.08%
2019 -132.422.000 -16.16%
2020 -51.563.000 -156.82%
2021 -609.410.000 91.54%
2022 646.203.000 194.31%
2023 82.955.000 -678.98%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Albemarle Corporation Operating Cashflow
Year Operating Cashflow Growth
2012 488.766.000
2013 432.859.000 -12.92%
2014 492.609.000 12.13%
2015 360.810.000 -36.53%
2016 735.524.000 50.95%
2017 303.979.000 -141.97%
2018 546.165.000 44.34%
2019 719.374.000 24.08%
2020 798.914.000 9.96%
2021 344.257.000 -132.07%
2022 1.907.849.000 81.96%
2023 628.853.000 -203.39%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Albemarle Corporation Capital Expenditure
Year Capital Expenditure Growth
2012 280.873.000
2013 155.346.000 -80.8%
2014 110.576.000 -40.49%
2015 227.649.000 51.43%
2016 196.654.000 -15.76%
2017 317.703.000 38.1%
2018 699.991.000 54.61%
2019 851.796.000 17.82%
2020 850.477.000 -0.16%
2021 953.667.000 10.82%
2022 1.261.646.000 24.41%
2023 545.898.000 -131.11%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Albemarle Corporation Equity
Year Equity Growth
2012 1.932.008.000
2013 1.742.776.000 -10.86%
2014 1.488.634.999 -17.07%
2015 3.401.313.000 56.23%
2016 3.942.604.000 13.73%
2017 3.817.696.000 -3.27%
2018 3.759.108.000 -1.56%
2019 4.093.580.000 8.17%
2020 4.468.594.000 8.39%
2021 5.805.607.000 23.03%
2022 8.190.846.999 29.12%
2023 10.162.439.000 19.4%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Albemarle Corporation Assets
Year Assets Growth
2012 3.437.291.000
2013 3.584.797.000 4.11%
2014 5.223.103.000 31.37%
2015 9.597.954.000 45.58%
2016 8.161.207.000 -17.6%
2017 7.750.772.000 -5.3%
2018 7.581.674.000 -2.23%
2019 9.860.863.000 23.11%
2020 10.450.946.000 5.65%
2021 10.974.118.000 4.77%
2022 15.456.522.000 29%
2023 18.883.354.000 18.15%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Albemarle Corporation Liabilities
Year Liabilities Growth
2012 1.505.283.000
2013 1.842.021.000 18.28%
2014 3.734.468.000 50.68%
2015 6.196.641.000 39.73%
2016 4.218.603.000 -46.89%
2017 3.933.076.000 -7.26%
2018 3.822.566.000 -2.89%
2019 5.767.283.000 33.72%
2020 5.982.352.000 3.6%
2021 5.168.511.000 -15.75%
2022 7.265.675.000 28.86%
2023 8.720.915.000 16.69%

Albemarle Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
83.95
Net Income per Share
28.23
Price to Earning Ratio
4.59x
Price To Sales Ratio
1.54x
POCF Ratio
6.41
PFCF Ratio
32.68
Price to Book Ratio
1.54
EV to Sales
1.38
EV Over EBITDA
5.19
EV to Operating CashFlow
5.72
EV to FreeCashFlow
29.24
Earnings Yield
0.22
FreeCashFlow Yield
0.03
Market Cap
15,19 Bil.
Enterprise Value
13,59 Bil.
Graham Number
231.11
Graham NetNet
-38.51

Income Statement Metrics

Net Income per Share
28.23
Income Quality
0.71
ROE
0.36
Return On Assets
0.09
Return On Capital Employed
0.03
Net Income per EBT
6.38
EBT Per Ebit
0.53
Ebit per Revenue
0.05
Effective Tax Rate
1.74

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.01
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.12
Operating Profit Margin
0.05
Pretax Profit Margin
0.03
Net Profit Margin
0.16

Dividends

Dividend Yield
0.01
Dividend Yield %
1.24
Payout Ratio
0.06
Dividend Per Share
1.6

Operating Metrics

Operating Cashflow per Share
20.18
Free CashFlow per Share
3.95
Capex to Operating CashFlow
-0.8
Capex to Revenue
-0.19
Capex to Depreciation
-5.15
Return on Invested Capital
0.15
Return on Tangible Assets
0.2
Days Sales Outstanding
43.55
Days Payables Outstanding
136.18
Days of Inventory on Hand
177.81
Receivables Turnover
8.38
Payables Turnover
2.68
Inventory Turnover
2.05
Capex per Share
-16.23

Balance Sheet

Cash per Share
13,61
Book Value per Share
84,08
Tangible Book Value per Share
70.47
Shareholders Equity per Share
84.08
Interest Debt per Share
28.72
Debt to Equity
0.34
Debt to Assets
0.18
Net Debt to EBITDA
-0.61
Current Ratio
1.81
Tangible Asset Value
8,30 Bil.
Net Current Asset Value
-1,60 Bil.
Invested Capital
0.34
Working Capital
3,18 Bil.
Intangibles to Total Assets
0.1
Average Receivables
1,26 Bil.
Average Payables
2,83 Bil.
Average Inventory
3531417500
Debt to Market Cap
0.22

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Albemarle Corporation Dividends
Year Dividends Growth
2018 1
2023 1 100%

Albemarle Corporation Profile

About Albemarle Corporation

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

CEO
Mr. Jerry Kent Masters Jr.
Employee
9.000
Address
4250 Congress Street
Charlotte, 28209

Albemarle Corporation Executives & BODs

Albemarle Corporation Executives & BODs
# Name Age
1 Mr. Jerry Kent Masters Jr.
Chairman, President & Chief Executive Officer
70
2 Ms. Kristin M. Coleman Esq.
Executive Vice President, General Counsel & Corporate Secretary
70
3 Mr. John Clarence Barichivich III
Vice President, Corporate Controller & Chief Accounting Officer
70
4 Dr. Glen Merfeld
Chief Technology Officer of Lithium Business
70
5 Mr. Eric W. Norris
President of Energy Storage
70
6 Mr. Netha N. Johnson Jr.
President of Specialties
70
7 Mr. Brian Tessin
Chief Tax Counsel & Vice President of Tax
70
8 Ms. Cynthia Renee Lima
Senior Vice President, Chief External Affairs & Communications Officer
70
9 Mr. Neal Sheorey
Executive Vice President & Chief Financial Officer
70
10 Ms. Melissa H. Anderson
Executive Vice President & Chief People Officer
70

Albemarle Corporation Competitors